Literature DB >> 7387140

Comparison of netilmicin and gentamicin pharmacokinetics in humans.

M Chung, R Costello, S Symchowicz.   

Abstract

In a crossover study, single doses of netilmicin and gentamicin were administered intramuscularly, each at 1.0 and 2.5 mg/kg. The serum concentrations, analyzed by a two-compartment open model with a first-order absorption, indicated that the pharmacokinetics of the drugs are essentially the same. Both drugs were rapidly absorbed and distributed after administration. No significant differences were observed between the two drugs in disposition half-life, rate of distribution and elimination, area under the serum concentration-time curve, urinary excretion, total body clearance, and renal clearance. After 1.0 mg/kg, the maximum serum concentration of netilmicin (5.18 microgram/ml) was only slightly lower than that for gentamicin (5.76 microgram/ml), but no difference was found after the 2.5-mg/kg dose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387140      PMCID: PMC283755          DOI: 10.1128/AAC.17.2.184

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Pharmacokinetic study of netilmicin.

Authors:  B R Meyers; S Z Hirschman; G Wormser; D Siegel
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  Netilmicin pharmacokinetics after single intravenous doses to elderly male patients.

Authors:  P G Welling; A Baumueller; C C Lau; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

3.  Comparative pharmacokinetics of tobramycin and gentamicin.

Authors:  C Regamey; R C Gordon; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

4.  [Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

Authors:  H Lode; B Kemmerich; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

5.  Gentamicin disposition and tissue accumulation on multiple dosing.

Authors:  J J Schentag; W J Jusko; J W Vance; T J Cumbo; E Abrutyn; M DeLattre; L M Gerbracht
Journal:  J Pharmacokinet Biopharm       Date:  1977-12

6.  Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors:  G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  Kinetics of netilmicin in man.

Authors:  J C Pechere; R Dugal; M M Pechere
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

8.  Tissue persistence of gentamicin in man.

Authors:  J J Schentag; W J Jusko; M E Plaut; T J Cumbo; J W Vance; E Abrutyn
Journal:  JAMA       Date:  1977-07-25       Impact factor: 56.272

9.  Pharmacokinetic studies of tobramycin and gentamicin.

Authors:  V K Simon; E U Mösinger; V Malerczy
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

10.  Netilmicin and gentamicin: comparative pharmacology in humans.

Authors:  L J Riff; G Moreschi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

  10 in total
  8 in total

1.  Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.

Authors:  C Lin; C Korduba; M Affrime; E Radwanski; A Nomeir; V Batra; D Cutler; M N Cayen
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

2.  Predicted tissue accumulation of netilmicin in patients.

Authors:  D J Edwards; A Mangione; T J Cumbo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

3.  In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.

Authors:  Michael J Zapor; Melissa Barber; Amy Summers; George H Miller; Lee Ann Feeney; Lynn E Eberly; Glenn Wortmann
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

4.  Pharmacokinetic study of sisomicin in humans.

Authors:  M Chung; J J Schrogie; S Symchowicz
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

5.  Pharmacokinetics of intravenously administered isepamicin in men.

Authors:  C C Lin; E Radwanski; C Korduba; M Cayen; M Affrime
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers.

Authors:  N E Winslade; M H Adelman; E J Evans; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 7.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

8.  Gentamicin pharmacokinetic changes in induced acute canine nephrotoxic glomerulonephritis.

Authors:  J E Riviere; G L Coppoc; E J Hinsman; W W Carlton
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.